文献速递胃肠外科围术期管理与 ERAS

混合腹腔镜-内镜技术用于复杂结直肠病变的系统综述

Hybrid laparo-endoscopic techniques for challenging colorectal lesions: a systematic review.
PubMed 文献 · Surg Endosc · 2025-09-29

汇总额外手术率5%(95%CI 3-8%),腺癌检出率12%(95%CI 8-16%),总体并发症7%(95%CI 5-10%),因并发症手术1%(95%CI 0-2%),中转开腹2%(95%CI 1-3%),局部复发3%(95%CI 2-6%)。结论认为该技术安全有效且可重复,但需术中应变和多学科协作。

要点

  • 混合腹腔镜-内镜切除复杂结直肠病变的汇总并发症率7%、局部复发率3%。
  • 术前分期局限,切除病变中12%检出腺癌,需术中应变与多学科协作。
  • 额外手术率5%,其中肿瘤学指征7%,中转开腹率仅2%。

核心结论

  • 混合腹腔镜-内镜切除对不适合标准内镜切除的复杂结直肠病变安全、有效且可重复。
  • 该技术并发症率和复发率低,同时保留肠管并减少结肠切除相关并发症。
  • 鉴于12%的意外腺癌发生率,术中应变能力和多学科专业知识至关重要。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索PubMed、Embase和Cochrane数据库(1985-2024)。
  • 纳入报告联合腹腔镜-内镜切除用于不适合标准内镜治疗的结直肠病变的研究。

主要发现

  • 额外手术汇总率为5%(95%CI 3-8%;I2=0%),其中肿瘤学指征为7%(95%CI 5-9%)。
  • 切除病变中腺癌检出率为12%(95%CI 8-16%)。
  • 总体并发症发生率为7%(95%CI 5-10%),因并发症需手术仅1%(95%CI 0-2%)。
  • 中转开腹率为2%(95%CI 1-3%)。
  • 长期随访局部复发率为3%(95%CI 2-6%;I2=0%)。

临床怎么用

  • 对于不适合标准内镜切除的大、纤维化或解剖困难的结直肠病变,可考虑混合腹腔镜-内镜切除。
  • 术前应认识到分期局限性,术中需具备应变能力并有多学科团队支持以处理意外腺癌。

局限性

  • 需要前瞻性多中心研究及标准化报告以优化患者选择并确认长期肿瘤学安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colorectal cancer screening has increased the detection of polyps requiring resection, but standard endoscopic techniques such as endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) are often unsuitable for large, fibrotic, or anatomically challenging lesions. Segmental colectomy remains definitive but carries substantial morbidity, particularly for benign disease. Laparo-endoscopic cooperative surgery (LECS) and related hybrid techniques have emerged as minimally invasive alternatives bridging the gap between endoscopic and surgical resection. METHODS: A systematic review was performed according to PRISMA guidelines, querying PubMed, Embase, and Cochrane databases (1985-2024). Studies reporting combined laparoscopic-endoscopic resections for colorectal lesions unsuitable for standard endoscopic treatment were included. Outcomes assessed included additional surgery, adenocarcinoma detection, complication rates, surgery for complications, conversion to open surgery, and recurrence. Random-effects models were used to calculate pooled proportions and 95% confidence intervals (CIs). RESULTS: Twenty-seven studies encompassing 1112 patients were included. The pooled rate of additional surgery was 5% (95% CI 3-8%; I2 = 0%), including 7% (95% CI 5-9%) for oncologic indications. Adenocarcinoma was identified in 12% of resected lesions (95% CI 8-16%), underscoring limitations of preoperative staging. Overall complications occurred in 7% (95% CI 5-10%), with surgery for complications required in only 1% (95% CI 0-2%). Conversion to open surgery occurred in 2% (95% CI 1-3%). Long-term follow-up demonstrated a local recurrence rate of 3% (95% CI 2-6%; I2 = 0%). CONCLUSIONS: Hybrid laparoscopic-endoscopic resections are safe, effective, and reproducible options for complex colorectal lesions not amenable to standard endoscopic resection. These techniques achieve low complication and recurrence rates while preserving bowel and minimizing morbidity associated with colectomy. Given the 12% incidence of unexpected adenocarcinoma, intraoperative adaptability and multidisciplinary expertise are essential. Prospective multicenter studies with standardized reporting are needed to refine patient selection and confirm long-term oncologic safety.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Distefano G, Ammirati CA, Barbiero M, et al. Hybrid laparo-endoscopic techniques for challenging colorectal lesions: a systematic review. Surg Endosc. 2025. PMID: 41023214. doi:10.1007/s00464-025-12243-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。